What about No­vavax? Vac­cine com­pa­ny's boost­er is left out of FDA ac­tion on Pfiz­er, Mod­er­na shots

The FDA’s ac­tion Mon­day clear­ing Mod­er­na and Pfiz­er/BioN­Tech’s lat­est mR­NA-based Covid-19 boost­ers begged a very large ques­tion: Why didn’t the agency act on No­vavax’s boost­er?

The agency’s an­nounce­ment made no men­tion of No­vavax’s shot, de­spite the com­pa­ny sub­mit­ting its boost­er ap­pli­ca­tion and ex­pect­ing a de­ci­sion soon. Al­though an ACIP meet­ing is sched­uled Tues­day to set a rec­om­men­da­tion for this year’s boost­ers, No­vavax said it doesn’t ex­pect to get an an­swer be­fore then.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER